Reading Time: 2 minutesIntroduction Cirrhosis, a progressive liver disease, poses significant challenges to medical professionals and patients alike. In the United States, it predominantly affects males, often stemming from chronic alcohol abuse, viral hepatitis, or non-alcoholic fatty liver disease. Serostim, a recombinant human growth hormone, has been explored as a potential therapeutic agent in managing cirrhosis. This article delves into a comprehensive analysis of Serostim therapy's effects on liver function in American males with cirrhosis, focusing on liver enzymes and patient outcomes over a decade. Liver Enzyme Profiles and Serostim Therapy Liver enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl … Continue reading →